I read the newly published article entitled "Randomized Controlled Trial to Compare the Safety and Efficacy of Tamsulosin, Solifenacin, and Combination of Both in Treatment of Double-J Stent--Related Lower Urinary Symptoms" by Shalaby and associates (1). They have concluded that combined tamsulosin and solifenacin regimen is effective to alleviate double-J stent related symptoms in comparison with both monotherapies. Ureteral stents, especially double-J stents, are associated with some discomforts and strategies implemented to attenuate those, including exact stent indications, stent insertion maneuvers, designation and administering drugs have been proposed so far (2). Given these notions, only three articles, including the mentioned study, have shown the effect of combination of adrenergic alpha-1 antagonist and anti-cholinergic on relieving ureteral stent-related symptoms (3, 4). All investigations have had some limitations based on study methods, but their findings are of great value for designing complementary investigations. Thanks to the investigators for their well-designed trial, but there are some thoughts to be mentioned.
analyzed cohort more homogeneous. Recently published randomized trial with main aim similar to this study (4) , has demonstrated findings close to this trial, although its contributors have analyzed the type of surgeries (URS and PCNL) separately and have shown findings, which were more generalizable.
Second concern is about the presentations of analyses through the article. As the authors reported in result section, pre-and post-insertion assessed scores showed some significant differences; however, these data were not reported in tables and only pre-insertion and 2 weeks post-insertion have been tabulated. In addition, if authors used on-way repeated measures ANOVA, reporting the p-value of this analysis is mandatory along with one-way ANOVA test. And also, there are no mention about analyses between control group and each monotherapy groups, which can be more useful than comparing monotherapy groups as shown in Table-3 . Post-hoc test used for paired analysis has not also been reported for pre-insertion scores, which are of great importance to show the lack of significant difference regarding baseline scores between groups.
Finally, the combined regimen of alpha-adrenergic and anti-cholinergic is a new effective strategy in urology settings for alleviating lower urinary tract symptoms in the background of some diseases, especially following urinary tract manipulation. Further large-scale clinical trials are needed to confirm this regimen for using in practice.
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